Keyphrases
Chromatin
100%
Prostate Cancer
71%
Chromatin Structure
57%
Tumor Cells
57%
Receptor Overexpression
42%
Cell-Associated
42%
Gene Regulatory Network
42%
Prostate Cancer Development
42%
Disease Progression
42%
Network Analysis
42%
Circadian Rhythm
42%
Prostate Cancer Progression
42%
Binding Dynamics
42%
Persistent Cells
42%
Single-cell Assay
42%
Prostate Cancer Relapse
42%
Epigenetic Dysregulation
42%
Assay for Transposase-Accessible Chromatin
42%
Cancer Types
42%
Human Prostate
42%
Cancer Therapeutics
42%
RNA Sequencing (RNA-seq)
42%
Androgen Receptor
42%
MRNA Expression
42%
Regulon
42%
JMJD6
42%
Lower Urinary Tract Symptoms
42%
Benign Prostatic Hyperplasia
42%
Therapeutic Response
42%
Ascitic Fluid
42%
Acellular
42%
Signaling Pathway
42%
Ovarian Cancer Cells
42%
Standard of Care
42%
Drug Response
42%
Patient-derived
42%
Circadian Rhythm Disorders
32%
Cancer Hallmarks
28%
Cell Population
28%
Tumor Progression
28%
Clinical Model
28%
Enzalutamide
28%
Fludarabine
28%
Phosphorylation
28%
Signal Transducer and Activator of Transcription 3
28%
Clinically Significant
28%
Chemoresistance
28%
Trametinib
28%
Human Ovarian Cancer Cell
28%
Treatment Resistance
28%
Medicine and Dentistry
Tumor Cell
53%
Disease Exacerbation
42%
Lower Urinary Tract Symptom
42%
Prostate Cancer
42%
Cancer Types
42%
Prostate Hypertrophy
42%
Regulon
42%
Gene Control
42%
Messenger RNA
42%
Circadian Rhythm
42%
Ovarian Cancer Cell Line
42%
Krukenberg Tumor
42%
Ascites Fluid
42%
Drug Response
42%
Cell Signaling Pathway
42%
Neoplasm
35%
Fludarabine
21%
Trametinib
21%
STAT3 Protein
21%
Drug Resistance
21%
Gene Regulatory Network
17%
Malignant Neoplasm
16%
Diseases
16%
Transcriptomics
12%
Recurrent Disease
10%
Metabolic Syndrome
10%
Cancer Recurrence
10%
Protein Kinase B
10%
Malignant Ascites
10%
Interleukin 6 Receptor
10%
Mitogen Activated Protein Kinase Kinase
10%
Phosphoinositide 3-Kinase
10%
Nuclear Factor
10%
In Vitro
10%
Incubation
10%
Immunoglobulin Enhancer Binding Protein
10%
Rapamycin
10%
Cell Line
10%
Ascites
10%
Cell Viability
10%
Drug Sensitivity
10%
Signaling Molecule
10%
Prostatectomy
7%
Specific Tumor
5%
Ploidy
5%
RNA Sequence
5%
Gene Mutation
5%
Genetic Heterogeneity
5%
Hormonal Regulation
5%
Sleep Disorder
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
85%
Prostate Cancer
85%
Neoplasm
58%
Ovary Cancer
42%
Ovary Carcinoma
42%
Messenger RNA
42%
Lower Urinary Tract Symptom
42%
Prostate Hypertrophy
42%
Ascites
42%
Disease Exacerbation
42%
Tumor Growth
28%
Carcinogenesis
28%
Drug Resistance
21%
Fludarabine
21%
STAT3 Protein
21%
Trametinib
21%
Recurrent Disease
16%
Cancer Recurrence
16%
Diseases
16%
Androgen
14%
Antiandrogen
14%
Phosphatidylinositol 3 Kinase
10%
Malignant Ascites
10%
Mitogen Activated Protein Kinase Kinase
10%
Protein Kinase B
10%
Rapamycin
10%
Metabolic Syndrome X
10%
Interleukin 6 Receptor
10%
Immunoglobulin Enhancer Binding Protein
10%
Cell Viability
10%
Nuclear Factor
10%
Disease Free Survival
5%
Urinary Tract Disease
5%
Survival Time
5%
Inflammation
5%
Sleep Disorder
5%
Transcription Factors
5%
